Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net income (loss)	$ (1,496)	$ 2,225	[1]
Adjustments to reconcile net income to net cash provided by operating activities:
Net realized losses (gains) on investments	68	130
Net losses (gains) on derivatives	2,658	1,436
Net losses (gains) on funds withheld reinsurance treaties	673	(1,028)
Net (gain) loss on market risk benefits	(174)	(1,907)	[2]
(Gain) loss from updating future policy benefits cash flow assumptions, net	14	15	[2]
Interest credited on other contract holder funds, gross	285	197
Mortality, expense and surrender charges	(132)	(135)
Amortization of discount and premium on investments	(6)	8
Deferred income tax expense (benefit)	(553)	411
Share-based compensation	24	71
Change in:
Accrued investment income	17	18
Deferred acquisition costs	163	137
Funds withheld, net of reinsurance	75	55
Other assets and liabilities, net	(155)	(800)
Net cash provided by (used in) operating activities	1,461	833
Sales, maturities and repayments of:
Debt securities	2,931	4,953
Equity securities	157	6
Mortgage loans	469	315
Purchases of:
Debt securities	(3,325)	(4,042)
Equity securities	(2)	(1)
Mortgage loans	(348)	(452)
Settlements related to derivatives and collateral on investments	(3,046)	(950)
Other investing activities	282	(31)
Net cash provided by (used in) investing activities	(2,882)	(202)
Policyholders' account balances:
Deposits	3,874	5,857
Withdrawals	(7,517)	(6,700)
Net transfers from (to) separate accounts	2,060	951
Proceeds from (payments on) repurchase agreements and securities lending	76	(990)
Net proceeds from (payments on) Federal Home Loan Bank notes	0	500
Net proceeds from (payments on) debt	(4)	(8)
Dividends on common stock	(51)	(52)
Purchase of treasury stock	(70)	(140)
Issuance of preferred stock	533	0
Net cash provided by (used in) financing activities	(1,099)	(582)
Net increase (decrease) in cash, cash equivalents, and restricted cash	(2,520)	49
Cash, cash equivalents, and restricted cash at beginning of period	4,301	2,631
Total cash, cash equivalents, and restricted cash at end of period	1,781	2,680
Supplemental cash flow information
Income taxes paid (received)	0	0
Interest paid	21	9
Non-cash investing activities
Debt securities acquired from exchanges, payments-in-kind, and similar transactions	32	112
Other invested assets acquired from stock splits and stock distributions	9	32
Non-cash financing activities
Non-cash dividend equivalents on stock-based awards	(3)	0
Reconciliation to Statement of Financial Position
Cash and cash equivalents	1,779	2,674
Restricted cash (included in Other assets)	2	6
Total cash, cash equivalents, and restricted cash	$ 1,781	$ 2,680

[1] (1) Recast for the adoption of ASU 2018-12. See Notes 1 and 2 to the Condensed Consolidated Financial Statements.

[2] (1) Recast for the adoption of ASU 2018-12. See Notes 1 and 2 to the Condensed Consolidated Financial Statements.